Paper39398174
Symmetrical Phosphinic Acids: Synthesis and Esterification Optimization toward Potential HIV Prodrugs.
Hayat K and 3 others. ACS Omega, 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Symmetrical Phosphinic Acids: Synthesis and Esterification Optimization toward Potential HIV Prodrugs. Papers, record 39398174. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39398174
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Symmetrical Phosphinic Acids: Synthesis and Esterification Optimization toward Potential HIV Prodrugs.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31488882 | Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression. | Cell Res | 2019 | https://conductscience.org/library/papers/31488882 | PubMed |
| 2 | 1637805 | Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays. | Biochemistry | 1992 | https://conductscience.org/library/papers/1637805 | PubMed |
| 3 | 15379718 | Lipid, sugar and liposaccharide based delivery systems 2. | Curr Med Chem | 2004 | https://conductscience.org/library/papers/15379718 | PubMed |
| 4 | 38007463 | Novel glycosyl prodrug of RXP03 as MMP-11 prodrug: design, synthesis and virtual screening. | BMC Chem | 2023 | https://conductscience.org/library/papers/38007463 | PubMed |
| 5 | 4159616 | Treatment of chronic portal-systemic encephalopathy with lactulose. | Lancet | 1966 | https://conductscience.org/library/papers/4159616 | PubMed |
| 6 | 35340621 | An ethnopharmacological review on the therapeutical properties of flavonoids and their mechanisms of actions: A comprehensive review based on up to date knowledge. | Toxicol Rep | 2022 | https://conductscience.org/library/papers/35340621 | PubMed |
| 7 | 2268900 | Hypoglycemic effect of intestinally administered monosaccharide-modified insulin derivatives in rats. | Chem Pharm Bull (Tokyo) | 1990 | https://conductscience.org/library/papers/2268900 | PubMed |
| 8 | 16983718 | Carbohydrates as scaffolds in drug discovery. | ChemMedChem | 2006 | https://conductscience.org/library/papers/16983718 | PubMed |
| 9 | 11472244 | Lipid, sugar and liposaccharide based delivery systems. | Curr Med Chem | 2001 | https://conductscience.org/library/papers/11472244 | PubMed |
| 10 | 9406592 | Intensely cytotoxic anthracycline prodrugs: glucuronides. | J Med Chem | 1997 | https://conductscience.org/library/papers/9406592 | PubMed |
| 11 | 35785277 | Unprecedented Convergent Synthesis of Sugar-Functionalization of Phosphinic Acids under Metal-Free Conditions. | ACS Omega | 2022 | https://conductscience.org/library/papers/35785277 | PubMed |
| 12 | 8259000 | Inhibitors of aspartyl proteinases. | Med Res Rev | 1993 | https://conductscience.org/library/papers/8259000 | PubMed |
| 13 | 30481556 | Phosphinic acids: current status and potential for drug discovery. | Drug Discov Today | 2019 | https://conductscience.org/library/papers/30481556 | PubMed |
| 14 | 24077675 | Glucose conjugation for the specific targeting and treatment of cancer. | Chem Sci | 2013 | https://conductscience.org/library/papers/24077675 | PubMed |
| 15 | 31900143 | Synthetic carbohydrate-based vaccines: challenges and opportunities. | J Biomed Sci | 2020 | https://conductscience.org/library/papers/31900143 | PubMed |
| 16 | 29946963 | Empagliflozin: A Review in Type 2 Diabetes. | Drugs | 2018 | https://conductscience.org/library/papers/29946963 | PubMed |
| 17 | 31236801 | Dapagliflozin: A Review in Type 2 Diabetes. | Drugs | 2019 | https://conductscience.org/library/papers/31236801 | PubMed |
| 18 | 23434657 | Flavonoids as antioxidants and developmental regulators: relative significance in plants and humans. | Int J Mol Sci | 2013 | https://conductscience.org/library/papers/23434657 | PubMed |
| 19 | 8347601 | Inhibition of human immunodeficiency virus-1 protease by a C2-symmetric phosphinate. Synthesis and crystallographic analysis. | Biochemistry | 1993 | https://conductscience.org/library/papers/8347601 | PubMed |
| 20 | 34171659 | Application of carbohydrates in approved small molecule drugs: A review. | Eur J Med Chem | 2021 | https://conductscience.org/library/papers/34171659 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41476560 | Highly Potent Phosphinic HIV‑1 Protease Inhibitors: Synthesis, In Vitro Evaluation, and Docking Studies. | ACS Omega | 2025 | https://conductscience.org/library/papers/41476560 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39398174
GET https://conductscience.org/api/papers/v1/39398174/references?page=2